Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

January 31, 2022

Conditions
Covid19
Interventions
DIETARY_SUPPLEMENT

OL-1, standard dose

The live microbial components have been present in the food supply, have a long history of safe use in foods, and are already marketed in the United States.

DIETARY_SUPPLEMENT

OL-1, high dose

The live microbial components have been present in the food supply, have a long history of safe use in foods, and are already marketed in the United States.

DIETARY_SUPPLEMENT

Placebo

Capsule containing inactive ingredients such as a product of potato starch (maltodextrin), but no probiotics.

Trial Locations (1)

08901

Rutgers University, New Brunswick

All Listed Sponsors
collaborator

Vault Health, Inc.

UNKNOWN

collaborator

Danisco USA Inc.

UNKNOWN

lead

Rutgers, The State University of New Jersey

OTHER